Chlorella powder inhibits the activities of peptidase cathepsin S, PLA2, cyclooxygenase-2, thromboxane synthase, tyrosine phosphatases, tumor necrosis factor-α converting enzyme, calpain and kinases

References

• Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998; 435(1)39–44
   PubMed Web of Science ®Google Scholar
• Blacker M, Noe MC, Carty TJ, Goodyer CG, LeBlanc AC. Effect of tumor necrosis factor-alpha converting enzyme (TACE) and metalloprotease inhibitor on amyloid precursor protein metabolism in human neurons. J Neurochem 2002; 83(6)1349–1357
   PubMedGoogle Scholar
• Borsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J Biol Chem 1998; 273(44)28766–28772
   PubMedGoogle Scholar
• Bromme D, Bonneau PR, Lachance P, Wiederanders B, Kirschke H, Peters C, Thomas DY, Storer AC, Vernet T. Functional expression of human cathepsin S in Saccharomyces cerevisiae. Purification and characterization of the recombinant enzyme. J Biol Chem 1993; 268(7)4832–4838
   PubMed Web of Science ®Google Scholar
• Celik T, Iyisoy A, Kursaklioglu H, Yuksel UC. Cyclooxygenase-2 inhibitors dilemma in cardiovascular medicine are all family members bad players?. Int J Cardiol 2007; 116(2)259–260
   PubMedGoogle Scholar
• Chan CC, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Ford-Hutchinson AW, Forrest MJ, Gauthier JY, Gordon R, Gresser M, Guay J, Kargman S, Kennedy B, Leblanc Y, Leger S, Mancini J, O¢neill GP, Ouellet M, Patrick D, Percival MD, Perrier H, Prasi P, Rodger I, Tagari P, Therien M, Vickers P, Visco D, Wang Z, Webb J, Wong E, Xu LJ, Young RN, Zamboni R, Riendeau D. Rofecoxib [Vioxx, MK-0966; 4-(4¢-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. J Pharmacol Exp Ther 1999; 290: 551–560
   PubMed Web of Science ®Google Scholar
• Cheng FC, Lin A, Feng JJ, Mizoguchi T, Takekoshi H, Kubota H, Kato Y, Naoki Y. Effects of Chlorella on activities of protein tyrosine phosphatases, matrix metalloproteinases, caspases, cytokine release, B and T cell proliferations, and phorbol ester receptor binding. J Med Food 2004; 7(2)146–152
   PubMedGoogle Scholar
• Dogné JM, Hanson J, de Leval X, Pratico D, Pace-Asciak CR, Drion P, Pirotte B, Ruan KH. From the design to the clinical application of thromboxane modulators. Curr Pharm Des 2006; 12(8)903–923
   PubMedGoogle Scholar
• Flannery T, McQuaid S, McGoohan C, McConnell RS, McGregor G, Mirakhur M, Hamilton P, Diamond J, Cran G, Walker B, Scott C, Martin L, Ellison D, Patel C, Nicholson C, Mendelow D, McCormick D, Johnston PG. Cathepsin S expression: an independent prognostic factor in glioblastoma tumours—a pilot study. Int J Cancer 2006; 119(4)854–860
   PubMed Web of Science ®Google Scholar
• Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci 2005; 118: 3829–3838
   PubMed Web of Science ®Google Scholar
• Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 2003; 83: 731–801
   PubMed Web of Science ®Google Scholar
• Hourani SM, Cusack NJ. Pharmacological receptors on blood platelets. Pharmacol Rev 1991; 43: 243–298
   PubMed Web of Science ®Google Scholar
• Hsiuan-Lin W, Ruey-Shyang H, Liang-Ping L. Identification of chlorella spp. isolates using ribosomal DNA sequences. Bot Bull Acad Sin 2001; 42: 115–121
   Google Scholar
• Inoue K, Mukaiyama Y, Oka H, Misawa H. Clinical effects of Chlorella in hypertensive men. J Jpn Soc Nutr Food Sci 1995; 48: 485–489
   Google Scholar
• Ivandic B, Castellani LW, Wang XP, Qiao JH, Mehrabian M, Navab M, Fogelman AM, Grass D, Swanson M, de Beer MC, de Beer F, Lusis AJ. Role of group II secretory phospholipase A2 in atherosclerosis. 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler Thromb Vasc Biol 1999; 19: 1284–1290
   PubMed Web of Science ®Google Scholar
• Jedinak A, Maliar T. Inhibitors of proteases as anticancer drugs. Neoplasma 2005; 52(3)185–192
   PubMedGoogle Scholar
• Jones SC. Relative thromboembolic risks associated with COX-2 inhibitors. Annals Pharmacother 2005; 39(7–8)1249–1259
   PubMedGoogle Scholar
• Kanouchi H, Okabe M, Doi S, Yamada H, Tachibana H, Yamada K. Dietary effect of Chlorella pyrenoidosa powder on immunoglobulin productivity of Sprague–Dawley rats. Nippon Shokuhin Kagaku Kaishi 2001; 48: 634–636
   Google Scholar
• Katsumata M, Gupta C, Goldman AS. A rapid assay for activity of phospholipase A2 using radioactive substrate. Anal Biochem 1986; 154: 676–681
   PubMedGoogle Scholar
• Komiyama K, Hirokawa Y, Morota T, Umezawa I. Antitumor activity and immunological response. Chemotherapy 1986; 32: 302–307
   Google Scholar
• Konishi F, Tanaka K, Himeno K, Taniguchi K, Nomoto K. Antitumor effect induced by a hot water extract of Chlorella vulgaris (CE): resistance to Meth-A tumor growth mediated by CE-induced polymorphonuclear leukocytes. Cancer Immunol Immunother 1985; 19: 73–78
   PubMed Web of Science ®Google Scholar
• Link J, Zipfel S. Advances in cathepsin S inhibitor design. Current Opin Drug Discov Dev 2006; 9(4)471–482
   PubMedGoogle Scholar
• Liu W, Spero DM. Cystein protease cathepsin S as a key step in antigen presentation. Drug News Perspect 2004; 17(6)357–363
   PubMedGoogle Scholar
• Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104(4)487–501
   PubMed Web of Science ®Google Scholar
• Miyazawa Y, Murayama T, Ooya N, Wang L.F, Tung YC, Yamaguchi N. Immunomodulation by a unicellular green algae (Chlorella pyrenoidosa) in tumor-bearing mice. J Ethnopharmacol 1988; 24: 135–146
   PubMed Web of Science ®Google Scholar
• Montalibet J, Skorey KI, Kennedy BP. Protein tyrosine phosphatase: enzymatic assays. Methods 2005; 35(1)2–8
   PubMedGoogle Scholar
• Morita K, Matsueda T, Iida T. Effects of Clorella, spirulina and chlorophyllin on fecal excretion of polychloronated dibenzo-p-dioxins in rats. Jpn J Toxicol Environ Health 1997; 43: 42–47
   Google Scholar
• Murachi T, Tanaka K, Itatanaka M, Murakami J. Intracellular Ca2 +-dependent protease (calpain) and its high-molecular-weight endogenous inhibitor (calpastatin). Adv Enzyme Regul 1980; 19: 407–424
   PubMedGoogle Scholar
• Murakami T, Iiduka Y, Okamoto K, Oogaki M. Effect of Chlorella on blood pressure, cerebral stroke lesions, hypertensive vascular changes and life-span in spontaneously hypertensive rats. J Jpn Soc Nutr Food Sci 1987; 40: 351–359
   Google Scholar
• Paul MK, Mukhopadhyay AK. Tyrosine kinase—role and significance in Cancer. Int J Med Sci 2004; 1: 101–115
   PubMed Web of Science ®Google Scholar
• Potapova O, Laird AD, Nannini MA, Barone A, Li G, Moss K, Cherrington JM, Mandel DB. Contribution of individual targets to the antitumor efficacy of the multitargeted receptor tyrosine kinase inhibitor SU11248. Mol Cancer Ther 2006; 5: 1280–1289
   PubMed Web of Science ®Google Scholar
• Riendeau D, Charleson S, Cromlish W, Mancini JA, Wong E, Guay J. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can J Physiol Pharmacol 1997; 75: 1088–1095
   PubMed Web of Science ®Google Scholar
• Samuelsson B, Goldyne M, Granstrom E, Hamberg M, Hammarstrom S, Malmsten C. Prostaglandins and thromboxanes. Annu Rev Biochem 1978; 47: 997–1029
   PubMed Web of Science ®Google Scholar
• Shi GP, Webb AC, Foster KE, Konell JH, Lemere CA, Munger JS, Chapman HA. Human cathepsin S: chromosomal localization, gene structure, and tissue distribution. J Biol Chem 1994; 269: 11530–11536
   PubMed Web of Science ®Google Scholar
• Shibata S, Orita K, Iwabuchi A, Misawa H. Serum cholesterol lowering action of hardly digestible fraction of chlorella. J Jpn Soc Nutr Food Sci 1998; 52: 100
   Google Scholar
• Soraya T, Karine C. Emerging role of cathepsin S in obesity and its associated diseases. Clin Chem Lab Med 2007; 45(3)328–332
   PubMedGoogle Scholar
• Stoker AW. Protein tyrosine phosphatases and signaling. J Endocrinol 2005; 185: 19–33
   PubMed Web of Science ®Google Scholar
• Takekoshi H, Mizoguchi T, Komasa Y, Chubachi H, Inoue Y, Imanishi H, Nakano M. Suppression of glutathione S-tansferase placental form-positive foci development in rat hepatocarcinogenesis by Chlorella pyrenoidosa. Oncol Rep 2005a; 14: 409–414
   PubMedGoogle Scholar
• Takekoshi, H, Suzuki, G, Chubachi, H, Nakano, M. 2005b. Effect of Chlorella pyrenoidosa on fecal excretion and liver accumulation of polychlorinated dibenzo-p-dioxane in mice. Chemosphere, 59:297–304.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Konishi F, Himeno K, Taniguchi K, Nomoto K. Augmentation of antitumor resistance by a strain of unicellular green algae, Cholrella vulgaris. Cancer Immunol Immunother 1984; 17: 90–94
   PubMed Web of Science ®Google Scholar
• Tanaka K, Koga T, Konishi F, Nakamura M, Mitsuyama M, Himeno K, Nomoto K. Augmentation of host defense by a unicellular green alga, Chlorella vulgaris, to Escherichia coli infection. Infect Immun 1986; 53: 267–271
   PubMed Web of Science ®Google Scholar
• Thurmond RL, Sun S, Karlsson L, Edwards JP. Cathepsin S inhibitors as novel immunomodulators. Curr Opin Investigat Drugs 2005; 6(5)473–482
   PubMedGoogle Scholar
• Togashi, N , Ura, N , Higashiura, K , Murakami, H , Shimamoto, K . 2002. Effect of TNF-alpha-converting enzyme inhibitor on insulin resistance in fructose-fed rats. Hypertension, 39(2 Pt 2):578–580.
   PubMedGoogle Scholar
• Wang B, Sun J, Kitamoto S, Yang M, Grubb A, Chapman HA, Kalluri R, Shi GP. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem 2006; 281(9)6020–6029
   PubMed Web of Science ®Google Scholar
• Welte S, Baringhaus KH, Schmider W, Muller G, Petry S, Tennagels N. 6,8-Difluoro-4-methylumbiliferyl phosphate: a fluorogenic substrate for protein tyrosine phosphatases. Anal Biochem 2005; 338(1)32–38
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH. Role of thromboxane in producing hepatic injury hepatic stress. Arch Surg 2005; 140(8)801–807
   PubMedGoogle Scholar